AWS: Boldly Going Where No Cloud Hyperscaler Has Gone Before
Cut through the hype with LNS Research Analyst Bob Francis as he covers the key takeaways from AWS re:Invent 2022 and 'the voyages of the Starship...
TOPIC
Manufacturing Execution System (MES)
Filter by:
iBASEt Excelerate 2022: Aerospace & Defense Manufacturing Wing Man
Discover new features, how the industry's reacting, and what the path forward looks like for iBaset customers from LNS Research Analyst Niels...
Waking Sleeping Giants...Releasing the Kraken
Based on recent developments, Principal Analyst Joe Perino, takes a closer look at automation vendors; their strategies, what’s happening, and why.
Data Contextualization - What's all the Hullabaloo?
Gain insights to the most frequently asked questions concerning DataOps and data contextualization when planning to scale in Industrial...
Pilot Purgatory in Industrial Transformation (IX) is Fake News
Tom Comstock explains why Pilot Purgatory in Industrial Transformation (IX) is Fake News, despite all the brouhaha currently surrounding the topic.
The “Holy Grail” and the “Puzzle” in Discrete and Batch Manufacturing Applications
Principal Analyst Tom Comstock navigates the Puzzle manufacturers face in Discrete and Batch Manufacturing searching for the Holy Grail of computing...
Should Pharma Regain MES Leadership or Become the New IX Leaders?
Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX
Don’t Let Your IIoT Program Succumb to Cultural Conflicts
Research Fellow Dan Miklovic explains how cultural wars inside organizations are inhibiting progress with IIoT programs.
The Pace of Technology Change is Turning Standardization in the Industrial Automation World Upside Down
Research Fellow Dan Miklovic explains how the pace of technology change is turning standardization in the industrial automation world upside down
Dassault Systèmes Analyst Day: Vive La Renaissance!
Coverage of Dassault Systèmes (3DS) annual industry analyst day, including thoughts on Medidata acquisition, BIOVIA, life sciences, DELMIA, and MOM.